1646862-09-0 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

5-?[[[(2,?4-?Difluorophenyl)?methyl]?amino]?carbonyl]?-?1,?4-?dihydro-?3-?methoxy-?4-?oxo-?1-?(2-?oxoethyl)?-2-?pyridinecarboxylic Acid Methyl Ester is an intermediate in the synthesis of Cabotegravir-d3 (C050102), which is the labelled form of Cabotegravir (C050100). Cabotegravir is a long acting HIV-1 integrase inhibitor with action against a broad range of HIV subtypes.

1646862-09-0 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

1646862-09-0 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Hangzhou MolCore BioPharmatech Co.,Ltd.	+86-057181025280; +8617767106207	sales@molcore.com	China	49734	58
Shanghai Dexuan Pharmaceutical Technology Co., Ltd	1701086315	dexuanpharma@126.com	China	9475	58
Henan Vcommend Consultrading Co., Ltd.	13393721940; 13393721940	sales@vcommend.com	China	10005	58
Pushan Industry (Shaanxi) Co., Ltd	029-81310890 18165209495	2929288192@qq.com	China	9999	58
TLC Pharmaceutical Standards Ltd.	18012923235	chinasales04@tlcstandards.com.cn	China	4916	58

---

• 5-[[[(2,4-Difluorophenyl)methyl]amino]carbonyl]-1,4-dihydro-3-methoxy-4-oxo-1-(2-oxoethyl)-2-pyridinecarboxylic Acid Methyl Ester
• 2-Pyridinecarboxylic acid, 5-[[[(2,4-difluorophenyl)methyl]amino]carbonyl]-1,4-dihydro-3-methoxy-4-oxo-1-(2-oxoethyl)-, methyl ester
• 1646862-09-0
• C18H16F2N2O6